Stratasys Ltd.
RELATED CONTENT
Stratasys Ltd. announced that surgeons at the University of Mainz Cardiothoracic and Vascular Surgery Department in Germany are using Stratasys PolyJet 3-D printing to transform the hospital’s surgical planning process for complex, life-critical vascular cases. According to the University hospital, the use of 3-D printed models for surgical planning has seen a significant reduction in costs at the institution when designing and fitting implants — while the hospital reports relevant time-savings during surgery, leading to an improvement in patient outcomes.
November 16, 2017 
Stratasys Ltd. announced last week enrollment is now open for 3DHEART, an investigator-initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3-D-printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.
March 13, 2017 
Stratasys Ltd., the 3-D printing and additive manufacturing solutions company, will be featured at the Healthcare Information and Management Systems Society (HIMSS) 2016 conference and exhibition. This is the first time 3-D printing will be a part of the annual conference, which will take place Feb. 29 – Mar. 4 in Las Vegas.
March 01, 2016